Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

October 18, 2021

Pink's Missing Link: Male Breast Cancer

Author(s):

Khevin Barnes

October reminds us that men get breast cancer, too. A male breast cancer survivor shares his thoughts about Breast Cancer Awareness Month. “Controversy creates conversation, and conversation incites action,” he writes.

Those of us with breast cancer are likely familiar with the October festivities that salute women and support fundraising campaigns that profess to offer hope for a cure. Breast cancer awareness is important of course, but making strides toward finding a cure for cancer demands more than awareness of the disease.

I like to think of “Pinktober” as it is often referred to – an opportunity to see breast cancer three-dimensionally; to look beyond the festivities and the fundraising and perhaps to even recognize it as a call to action for the men who have been diagnosed with the disease. But more importantly, this is a great month to reach the guys who probably don’t realize that male breast cancer is real—and it’s not always pink.

The ribbon that seems to wrap around our planet each October is widely seen as the official symbol of breast cancer — at least of the female variety. It’s highly recognizable and carries a strong psychological tug, and is most often associated with the Susan G. Komen group, but that isn’t exactly where it started.

By the way, no single company or organization or foundation owns this worldwide symbol, although individual pink ribbon designers can hold the rights on their own designs. As an example, Avon has its own, as does Estée Lauder.

Charlotte Haley, who battled breast cancer, introduced the concept of a peach-colored breast cancer awareness ribbon. In the early 1990s, 68-year-old

Haley began making ribbons by hand in her home. Her daughter, sister and grandmother had breast cancer. She distributed thousands of ribbons at supermarkets with cards that read: “The National Cancer Institute annual budget is $1.8 billion, only 5 percent goes for cancer prevention. Help us wake up our legislators and America by wearing this ribbon.”

As the word spread, executives from Estée Lauder and Self Magazine asked Haley for permission to use her ribbon, but she refused, saying the companies were too commercial. But Self Magazine was determined to use her ribbon. The magazine’s lawyers advised coming up with another color. In the end they chose pink, a color that focus groups said was “soothing, comforting and healing.” And even though those words hardly describe the reality of breast cancer, that pink ribbon has come to represent the women of the world who suffer from the disease.

I for one celebrate with the women survivors of breast cancer and join them in our mutual goal of eradicating the disease forever. Despite the controversy that surrounds the unbridled merchandizing that distorts the message this October, the truth is that controversy creates conversation, and conversation incites action. Hopefully, “Pinktober” will whip up the proverbial cancer paint pot and stir a healthy dose of blue into the mix.

At the end of the day, or at least at the end of the month, the breast cancer movement is much bigger than October, and it isn’t only about finding a cure or getting a mammogram or raising money. It’s a crusade that should unite men and women together through prevention and education and support.

“The breast of both worlds,” you might say.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Related Content
Advertisement
Marissa is a “GenXer” living as a “flattie” with metastatic breast cancer since March 2014. Read more of Marissa's blogs here!
May 10th 2025

When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound

Marissa Holzer
A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Linda Cohen is a survivor of small lymphocytic lymphoma and was diagnosed in 2009. Catch up on all of Linda's blogs here!
May 9th 2025

A Thank You to Nurses and the Support That Lasts Beyond Cancer Care

Linda Cohen
After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
An Enhertu regimen significantly improved pathologic complete responses for high-risk HER2+ early-stage breast cancer: © karrastock - stock.adobe.com
May 7th 2025

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

Spencer Feldman
Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.
Image of two woman with ribbons.
May 7th 2025

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

Connie Pombo
After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.
Related Content
Advertisement
Marissa is a “GenXer” living as a “flattie” with metastatic breast cancer since March 2014. Read more of Marissa's blogs here!
May 10th 2025

When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound

Marissa Holzer
A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Linda Cohen is a survivor of small lymphocytic lymphoma and was diagnosed in 2009. Catch up on all of Linda's blogs here!
May 9th 2025

A Thank You to Nurses and the Support That Lasts Beyond Cancer Care

Linda Cohen
After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
An Enhertu regimen significantly improved pathologic complete responses for high-risk HER2+ early-stage breast cancer: © karrastock - stock.adobe.com
May 7th 2025

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

Spencer Feldman
Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.
Image of two woman with ribbons.
May 7th 2025

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

Connie Pombo
After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.